Michael Hess leads the firm’s Specialty Pharmacy & Pharmaceuticals Practice Group. His ability to balance legal issues with business issues has earned him a reputation as a go-to lawyer in the specialty pharmacy industry.
Mike’s ability to provide practical and impactful advice to specialty pharmacies is rooted in his first-hand experience as former Chief Counsel & VP of Strategic Development of Accredo Health Group, former Assistant General Counsel of Medco Health Solutions and as a private practice attorney to the industry. He now supports 40 percent of the largest independent specialty pharmacy companies located from Los Angeles to Orlando, serving as the outside general counsel. In addition, he has participated in many of the specialty pharmacy transactions coming to market during the past three years. Mike’s strategic business advice and transactional and regulatory guidance helps manufacturers and pharmacies get high-cost, complex specialty drugs from the manufacturer’s warehouse to the patient’s door, safely, legally, effectively and efficiently.
American Health Law Association (AHLA) — RAP Practice Group, Vice Chair (2004-2007)
Institute for Health Law & Policy (iHeLP), University of Memphis Cecil C. Humphreys School of Law — Advisory Board
Memphis Leadership Academy — Board of Trustees
National Infusion Center Association — Advisory Board
Make-a-Wish of the Mid-South — Board of Directors
Representation of Nuvem, a healthcare software technology and consulting services company, in their acquisition of Apovia, a pharmacy services management company. Terms of the transaction were not disclosed.
Representation of RxSense, a healthcare pharmacy benefits administration technology company, in their acquisition of ParamountRx, a prescription medicine discount plan company. Terms of the transaction were not disclosed.
Representation of Consonance Capital, a private equity manager focused exclusively on the healthcare industry, in their recapitalization of Orsini Pharmaceutical Services, a leading nationwide specialty pharmaceutical provider. Terms of the transaction were not disclosed.
Representation of Blue Fin Group, a full-service professional management consulting firm delivering research, strategy, and implementation services to help manufacturers optimize access, in its sale to IntegriChain, a comprehensive data and business process platform for Life Sciences market access. Terms of the transaction were not disclosed.
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
Representation of Kinderhook Industries, LLC in its investment in AbsoluteCARE, value-based primary care provided headquartered in Baltimore, Maryland, for $105 million. Kinderhook Industries, LLC is a private investment firm that manages over $3.3 billion of committed capital.
Representation of Linden Capital Partners, a Chicago-based healthcare private equity firm, as healthcare regulatory counsel in its acquisition of UroGPO from Nautic Partners. UroGPO is a urology-specific Group Purchasing Organization and provider of educational programs for providers.
Chambers USA — Healthcare (2016-2023)
BTI Client Service All-Stars (2016, 2019)
Martindale-Hubbell — AV Preeminent® Peer Review Rated
The Best Lawyers in America© — Health Care Law (2014-2023)
Best Lawyers® — Memphis Health Care Law “Lawyer of the Year” (2018)
Client Choice Award — Healthcare & Life Sciences (2019)
Mid-South Super Lawyers (2009, 2018-2022)